Kymera Therapeutics Reports Shareholder Vote Matters
Ticker: KYMR · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1815442
| Field | Detail |
|---|---|
| Company | Kymera Therapeutics, Inc. (KYMR) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: KYMR
TL;DR
Kymera shareholders voted on important company matters on June 25th.
AI Summary
Kymera Therapeutics, Inc. filed an 8-K on June 27, 2025, reporting on matters submitted to a vote of security holders on June 25, 2025. The filing details the company's corporate actions and decisions put before its shareholders for approval.
Why It Matters
This filing indicates key corporate governance decisions were made, which could impact the company's strategic direction and shareholder rights.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing shareholder votes, not indicating new financial risks or operational changes.
Key Players & Entities
- Kymera Therapeutics, Inc. (company) — Registrant
- June 27, 2025 (date) — Filing Date
- June 25, 2025 (date) — Date of Earliest Event Reported
FAQ
What specific matters were submitted to a vote of Kymera Therapeutics' security holders?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
When did the earliest event reported in this 8-K filing occur?
The earliest event reported occurred on June 25, 2025.
What is the filing date of this 8-K report?
The filing date of this 8-K report is June 27, 2025.
What is the principal executive office address for Kymera Therapeutics, Inc.?
The principal executive offices are located at 500 North Beacon Street, 4th Floor, Watertown, Massachusetts 02472.
What is Kymera Therapeutics' telephone number?
Kymera Therapeutics' telephone number is (857) 285-5300.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding Kymera Therapeutics, Inc. (KYMR).